These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37976261)

  • 21. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
    Martin JE; Nguyen TT; Grunseich C; Nofziger JH; Lee PR; Fields D; Fischbeck KH; Foran E
    J Neurosci; 2017 May; 37(21):5309-5318. PubMed ID: 28450545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H; Feng Z; Mazzasette C; Glascock JJ; Valdivia D; Pyles N; Crawford TO; Swoboda KJ; Patitucci TN; Ebert AD; Sumner CJ; Ko CP; Lorson CL
    Hum Mol Genet; 2015 Jul; 24(14):4094-102. PubMed ID: 25911676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway.
    D'Amico D; Biondi O; Januel C; Bezier C; Sapaly D; Clerc Z; El Khoury M; Sundaram VK; Houdebine L; Josse T; Della Gaspera B; Martinat C; Massaad C; Weill L; Charbonnier F
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12816. PubMed ID: 35338505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
    Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
    Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
    Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
    Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy.
    Hunter G; Powis RA; Jones RA; Groen EJ; Shorrock HK; Lane FM; Zheng Y; Sherman DL; Brophy PJ; Gillingwater TH
    Hum Mol Genet; 2016 Jul; 25(13):2853-2861. PubMed ID: 27170316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.
    Simon CM; Blanco-Redondo B; Buettner JM; Pagiazitis JG; Fletcher EV; Sime Longang JK; Mentis GZ
    J Neurosci; 2021 Jan; 41(2):376-389. PubMed ID: 33219005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability.
    Liu H; Lu J; Chen H; Du Z; Li XJ; Zhang SC
    Sci Rep; 2015 Jul; 5():12189. PubMed ID: 26190808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction.
    Torri F; Mancuso M; Siciliano G; Ricci G
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished motor neuron activity driven by abnormal astrocytic EAAT1 glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery.
    Welby E; Ebert AD
    Glia; 2023 May; 71(5):1311-1332. PubMed ID: 36655314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell cycle inhibitors protect motor neurons in an organoid model of Spinal Muscular Atrophy.
    Hor JH; Soh ES; Tan LY; Lim VJW; Santosa MM; Winanto ; Ho BX; Fan Y; Soh BS; Ng SY
    Cell Death Dis; 2018 Oct; 9(11):1100. PubMed ID: 30368521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
    Wen HL; Ting CH; Liu HC; Li H; Lin-Chao S
    Neurobiol Dis; 2013 Apr; 52():94-103. PubMed ID: 23268200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of Aldh1a2 underlies motor neuron degeneration in spinal muscular atrophy.
    Kataoka M; Sahashi K; Tsujikawa K; Takeda JI; Hirunagi T; Iida M; Katsuno M
    Neurosci Res; 2023 Sep; 194():58-65. PubMed ID: 37146794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor defects in a Drosophila model for spinal muscular atrophy result from SMN depletion during early neurogenesis.
    Grice SJ; Liu JL
    PLoS Genet; 2022 Jul; 18(7):e1010325. PubMed ID: 35877682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
    J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
    de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
    Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model.
    Ando S; Funato M; Ohuchi K; Kameyama T; Inagaki S; Seki J; Kawase C; Tsuruma K; Shimazawa M; Kaneko H; Hara H
    Eur J Pharmacol; 2017 Nov; 814():161-168. PubMed ID: 28826912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice.
    Neve A; Trüb J; Saxena S; Schümperli D
    Mol Cell Neurosci; 2016 Jan; 70():30-41. PubMed ID: 26621405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models.
    de la Fuente S; Sansa A; Hidalgo I; Vivancos N; Romero-Guevara R; Garcera A; Soler RM
    Cell Death Dis; 2020 Jun; 11(6):487. PubMed ID: 32587237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
    Feng Z; Lam S; Tenn ES; Ghosh AS; Cantor S; Zhang W; Yen PF; Chen KS; Burden S; Paushkin S; Ayalon G; Ko CP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.